ELIZABETH TEMPLEMAN: Open Payments
NPI 1164735189 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,024 in 122 payments from 22 companies in 2025. Trend: 2023 $3,739 · 2024 $3,487 · 2025 $3,024
Food & beverage: $3,024
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $648 |
| Noven Therapeutics, LLC | 12 | $312 |
| ABBVIE INC. | 4 | $286 |
| Corium, LLC | 11 | $276 |
| Otsuka America Pharmaceutical, Inc. | 7 | $234 |
| Axsome Therapeutics, Inc. | 9 | $229 |
| Teva Pharmaceuticals USA, Inc. | 9 | $190 |
| Vanda Pharmaceuticals Inc. | 10 | $179 |
| Alkermes, Inc. | 7 | $139 |
| Collegium Pharmaceutical, Inc. | 5 | $104 |
Products named: CAPLYTA, Xelstrym, Azstarys, VRAYLAR, REXULTI, Auvelity, AUSTEDO XR, FANAPT.
Industry payments across KY — which companies pay providers there.
